Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 681 of 1,261
  1. US 9402807

    Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

    Rani Therapeutics, LLC · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted
  2. US 9402806

    Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

    Rani Therapeutics, LLC · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted
  3. US 9403908

    Method for altering hematopoietic progenitor cell adhesion, differentiation, and migration

    The Regents of the University of California · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted
  4. US 9403856

    Bcl-2/Bcl-xL inhibitors and therapeutic methods using the same

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted
  5. US 9403872

    Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors

    The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted
  6. US 9403885

    Wnt compositions and therapeutic uses of such compositions

    Fate Therapeutics, Inc. · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted
  7. US 9403832

    Pyrazolo[1,5-a]pyrimidine-based compounds, compositions comprising them, and methods of their use

    LEXICON PHARMACEUTICALS, INC. · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted
  8. US 9403839

    Pyran-spirocyclic piperidine amides as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted
  9. US 9403815

    Compounds and uses thereof in modulating levels of various amyloid beta peptide alloforms

    The Regents of the University of California · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted
  10. US 9403802

    Heterocyclic compound and use therefor

    Takeda Pharmaceutical Company Limited · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted
  11. US 9403800

    Compounds for inhibition of cancer cell proliferation

    ChemRegen, Inc. · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted
  12. US 9403814

    Crystalline forms of dihydropyrimidine derivatives

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted
  13. US 9403811

    Crystalline forms of azilsartan medoxomil potassium and preparation and uses thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted
  14. US 9403002

    Swallowable capsule and method for stimulating incretin production within the intestinal tract

    Rani Therapeutics, LLC · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted
  15. US 9403783

    Methods for producing viloxazine salts and novel polymorphs thereof

    Supernus Pharmaceuticals, Inc. · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted
  16. US 9403778

    Agents that prevent or repair skin damage

    Regents of the University of Minnesota · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted
  17. US 9402911

    Multifunctional small molecules

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted
  18. US 9402889

    Live, oral vaccine for protection against Shigella dysenteriae serotype 1

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted
  19. US 9404114

    Antisense modulation of GCGR expression

    Ionis Pharmaceuticals, Inc. · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted
  20. US 9402879

    Methods and compositions for modulating PD1

    Sangamo Biosciences, Inc. · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted
  21. US 9402850

    BAX agonist, compositions, and methods related thereto

    The Board of Regents of the University of Texas System · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted
  22. US 9402876

    Method and pharmaceutical composition for hair growth

    The Regents of the University of California · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted
  23. US 9403819

    Apoptosis signal-regulating kinase 1 inhibitors

    Takeda Pharmaceutical Company Limited · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted
  24. US 9402935

    Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs

    Lutonix, Inc. · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.